Xilio Therapeutics, Inc. (XLO)
NASDAQ: XLO · Real-Time Price · USD
0.930
-0.130 (-12.26%)
At close: Feb 21, 2025, 4:00 PM
0.915
-0.015 (-1.61%)
After-hours: Feb 21, 2025, 7:59 PM EST
Xilio Therapeutics Market Cap
Xilio Therapeutics has a market cap or net worth of $42.52 million as of February 21, 2025. Its market cap has increased by 151.91% in one year.
Market Cap
42.52M
Enterprise Value
-10.33M
1-Year Change
151.91%
Ranking
Category
Stock Price
$0.93
Market Cap Chart
Since the IPO on October 22, 2021, Xilio Therapeutics's market cap has decreased from $426.71M to $42.52M, a decrease of -90.04%. That is a compound annual growth rate of -49.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 42.52M | -2.62% |
| Dec 31, 2024 | 43.66M | 188.36% |
| Dec 29, 2023 | 15.14M | -79.46% |
| Dec 30, 2022 | 73.73M | -83.14% |
| Dec 31, 2021 | 437.33M | 2.49% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 784.21B |
| UnitedHealth Group | 462.37B |
| Johnson & Johnson | 384.45B |
| Novo Nordisk | 370.84B |
| AbbVie | 354.62B |
| Abbott Laboratories | 230.98B |
| AstraZeneca | 227.07B |
| Merck & Co. | 221.80B |